Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium.
about
Haemophilic patients with inhibitors to factor VIII or IX: variables affecting treatment response.Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literature.Continuous infusion of coagulation factor products.Continuous infusion of coagulation factors.Orthopaedic surgery in haemophilic patients with inhibitors: an overview.Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors.Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors.Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patientsRecombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven).Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa.Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism.A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation.Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases.Concurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusion.The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience.Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
P2860
Q34117215-88C885B0-ECCA-4F6A-8593-097D5260FFB4Q34266416-5376E77D-AFFF-4BC8-A4E9-DDC7BF6E0908Q34615620-C455EB98-ACD8-4B41-BE2D-F642E3D09AB2Q34636862-20E2BD20-297E-441F-89E2-2488B64B10E6Q34636994-3534965A-2C5F-47EF-9D73-194E21D086BDQ35771690-E4393916-A05F-4C76-8E6F-491DBBE4CDE0Q36291064-BBE19256-CB60-4003-B323-3023438B1061Q36745575-0DC4BACB-DA7D-4963-9F62-8DB94C4C9FD4Q37032862-D521D997-B586-489B-9D02-A1953B419DCCQ37835878-14222C2C-75C3-4A04-8530-F778BD6BEAE7Q37845931-D9C13991-060E-4D61-8BF0-98A23C489EFCQ39392420-C0F32704-E5E8-4D15-8F7D-CC489D3203F8Q43548835-B28004E2-83A7-4D82-96B7-931D470CF133Q44537661-895EAE5A-8244-4C0F-9780-E211DE5D24EAQ45858938-6BCD3513-10EF-4869-88F4-3ECDA440A527Q45871233-5BC5E7B3-3B3D-47A3-A7D9-AF642202DDDFQ45872091-958F18AA-538E-4DB7-B8D8-FBCC689A1DC6Q45872630-DA30D834-A452-4281-B913-8FECD647B672Q45879743-36DE204D-590F-4C37-B7F1-7CE7F07C2CB6Q45888814-4F157C29-98FF-49EA-8465-CFF613F983B4
P2860
Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Continuous infusion of recombi ...... n The Netherlands and Belgium.
@en
Continuous infusion of recombi ...... n The Netherlands and Belgium.
@nl
type
label
Continuous infusion of recombi ...... n The Netherlands and Belgium.
@en
Continuous infusion of recombi ...... n The Netherlands and Belgium.
@nl
prefLabel
Continuous infusion of recombi ...... n The Netherlands and Belgium.
@en
Continuous infusion of recombi ...... n The Netherlands and Belgium.
@nl
P2093
P921
P1476
Continuous infusion of recombi ...... n The Netherlands and Belgium.
@en
P2093
Mauser-Bunschoten EP
Peerlinck K
Wielenga JJ
de Goede-Bolder A
P304
P356
10.1016/S0300-2977(98)00111-9
P577
1998-12-01T00:00:00Z